ArticleChest2021
Survival and Lung Transplant Outcomes for Individuals With Advanced Cystic Fibrosis Lung Disease Living in the United States and Canada: An Analysis of National Registries.
Article in Chest, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Exploring the utilisation and effectiveness of implementation science strategies by cystic fibrosis registries for healthcare improvement: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2025Pooled it
- Patient-centred understanding of quality of life, symptoms, health equity in cystic fibrosis (PULSE-CF): study protocol for an observational study.BMJ open respiratory research · 2026Article
- The Changing Transplant Landscape in the Era of Elexacaftor/Tezacaftor/Ivacaftor: A Word of Caution.Clinical transplantation · 2025Article
- Linkage of the CF Foundation Patient Registry with the Scientific Registry of Transplant Recipients database.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025Article
- A dramatic decline in lung transplantation for cystic fibrosis in the United States.CHEST pulmonary · 2024Article
- Lung Allocation Score Exceptions in Persons with Cystic Fibrosis Undergoing Lung Transplant.Annals of the American Thoracic Society · 2024Article
- Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry.Annals of the American Thoracic Society · 2023Article
- Cystic fibrosis survival outcomes following second lung transplant: The north American experience.Clinical transplantation · 2023Article
- Hemoptysis and the Risk for Lung Transplant or Death without Transplant in Individuals with Cystic Fibrosis in the United States.Annals of the American Thoracic Society · 2022Review
- Survival of people with cystic fibrosis in Australia.Scientific reports · 2022Article
- Article
- Survival difference between high-risk and low-risk CFTR genotypes after lung transplant.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022Article
- Lung Transplantation Disparities among Patients with IPF: Recognition and Remedy.Annals of the American Thoracic Society · 2022Article
- Low body mass index as a barrier to lung transplant in cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022Article
- A Framework for Using Real-World Data and Health Outcomes Modeling to Evaluate Machine Learning-Based Risk Prediction Models.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2022Article
- Improving lung transplant outcomes in France: the high emergency lung transplantation programme.The European respiratory journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundUnderstanding how health outcomes differ for patients with advanced cystic fibrosis (CF) lung disease living in the United States compared with Canada has health policy implications. RESEARCH QUESTION: What are rates of lung transplant (LTx) and rates of death without LTx in the United States and Canada among individuals with FEV STUDY DESIGN AND
methodsThis was a retrospective population-based cohort study, 2005 to 2016, using the US CF Foundation, United Network for Organ Sharing, and Canadian CF registries. Individuals with CF and at least two FEV
resultsThere were 5,899 patients (53% male) and 905 patients (54% male) with CF with FEV
interpretationThere are lower rates of LTx and an increased risk of death without LTx for US patients with CF with FEV
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.